Pacific Bio (PACB) Tops Q2 EPS by 4c

Pacific Bio (NASDAQ: PACB) reported Q2 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $39.8 million versus the consensus estimate of $36.66 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results